Wet Wipes Market Set to Nearly Double by 2033, Projected to Reach USD 9.22 Billion at a 7.8% of CAGR

Wet Wipes Market
Wet Wipes Market

The wet wipes market has generated an impressive USD 4.3 billion in revenue in 2023, with expectations for substantial growth in the coming decade. According to industry forecasts, the market is projected to expand to USD 9.22 billion by 2033, reflecting a compound annual growth rate (CAGR) of 7.8% from 2023 to 2033.

This significant growth is driven by the increasing use of wet wipes for hygiene purposes, especially in regions where access to clean water is limited. The convenience and effectiveness of wet wipes in preventing infections and maintaining cleanliness, coupled with their disposable nature, have led to a surge in consumer demand.

The wet wipes market is benefiting from a broader acceptance of these products across various applications, including personal hygiene, household cleaning, and medical use. As consumers continue to prioritize convenience and hygiene, the market is expected to see continued expansion and innovation.

Market competitors are introducing eco-friendly and biodegradable Wet Wipes produced from wood pulp and cotton as an alternative for synthetic fibres, which is driving wet wipe sales.

The rising prevalence of health-related illnesses in the elderly, such as incontinence-associated dermatitis (IAD) and catheter-associated urinary tract infection (CAUTI), is driving up demand for Wet Wipes, particularly in hospitals.

Wet Wipes are expected to gain traction over the forecast period because they efficiently serve the objective of maintaining hygiene standards and removing germs, dirt, and dust build-up on the skin and other physical surfaces.

In addition, the rise of local and small players, creative product development, clever marketing strategies implemented by top manufacturers, and commercialization of Wet Wipes are increasing the global Wet Wipes market’s growth prospects.

The FMI study projects the US to lead the North America Wet Wipes market. Rapid expansion of distribution channels, coupled with increasing per capita healthcare expenditure are anticipated to bode well for the Wet Wipes market in the U.S.

“Expansion of the ecommerce sector is resulting in easy availability and increasing sales of Wet Wipes across the globe. In addition to this, government-backed healthcare reimbursement plans will continue driving sales of Wet Wipes over the forecast period,” says the FMI analyst.

Key Takeaways:

  • Incontinence wipes are expected to account for roughly 27% of the worldwide Wet Wipes market share during the forecast period.
  • The hospital segment is expected to increase at a 6% CAGR through 2031 in terms of end users.
  • It is estimated that the United States accounts for more than 80% of the North American Wet Wipes market.
  • Germany will dominate the European Wet Wipes industry in 2021, accounting for 23% of the market.
  • China is expected to emerge as a profitable market, accounting for 40% of the East Asian Wet Wipes market share.
  • The Japanese Wet Wipes market is expected to develop at a 9.3% CAGR through 2031, while the South Korean Wet Wipes market is expected to rise at a robust 10% CAGR.

Prominent Drivers:

  • Collaborations among key market players to launch innovative products will provide tailwinds to Wet Wipes sales during the assessment period.

Restraints:

  • Availability of cheaper alternatives such as soaps, cleansing milk, and face washes might hamper sales of Wet Wipes.
  • Chances of allergic reactions and irritability on the skin might result in decreased sales of Wet Wipes.

Competitive Landscape

Leading players operating in the global Wet Wipes market are aiming to expand their global footprint through strategic collaborations, mergers, and acquisitions. In addition to this, launching innovative products, research, and development and strengthening distribution channels will remain key growth strategies among players. For instance:

  • Medline partnered with Intelligent Observation (IO) in January 2021 to help healthcare professionals manage healthcare-associated infection rates.
  • Essity announced the acquisition of ABIGO Medical, a wound care company, and Asaleo Care, an Australian hygiene company, in July 2021.

Leading players operating in Wet Wipes Market profiled by FMI include:

  • Essity Aktiebolag (publ)
  • Kimberly-Clark
  • Procter & Gamble
  • Cardinal Health
  • Medtronic
  • Stryker
  • Coloplast
  • Others

A Old Full Report Analysis Click Here

More Insights on FMI’s Wet Wipes Market

The latest market study on the Wet Wipes market by Future Market Insights gives a detailed segmentation for the forecast period of 2021 to 2031. In order to gain a better perspective of the global Wet Wipes market potential, its growth, trends, and opportunities, the market is segmented on the basis of:

Product:

  • Incontinence wipes
    • Baby Wipes
    • Adult Wipes
  • Skin Antiseptic Wipes
  • Feminine Hygiene Wipes
  • Skin Care Wet Wipes
  • Sterile Wound Cleansing Wipes

Disposability:

  • Flushable Wipes
  • Non-Flushable Wipes

Application:

  • Incontinence
  • Skincare
  • Personal Hygiene
  • Wound Care

End-User:

  • Hospitals
  • Clinics
  • Specialty Centers
  • Long term care centers
  • Homecare Settings

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Ocular Drug Delivery System Market Projected to Reach USD 31,410.2 Million by 2033 at a 6.9% of CAGR

Ocular Drug Delivery System Industry
Ocular Drug Delivery System Industry

The ocular drug delivery system market is set to surpass USD 16,159.9 million in 2023, according to a recent report by Future Market Insights. This growth is driven by an increasing prevalence of ophthalmic diseases and a rising emphasis on advanced treatment options, which are fueling demand for innovative ocular drug delivery systems.

The market is forecasted to grow at a robust compound annual growth rate (CAGR) of 6.9% from 2023 to 2033. By the end of this forecast period, the market is expected to reach an impressive USD 31,410.2 million.

A significant factor contributing to this growth is the high demand for particulate drug delivery systems, which are anticipated to dominate the market, accounting for over 70% of global sales in 2023. These systems are favored for their effectiveness in delivering targeted therapies to the ocular region.

To overcome the ocular drug delivery barriers and improve ocular bioavailability, various conventional and novel drug delivery systems have been developed such as ointments, emulsions, suspensions, aqueous gels, Nano micelles, liposomes, and in situ thermosensitive gels for the earlier mentioned ocular diseases.

Glaucoma is the second-leading cause of blindness worldwide, accounting for up to 8% of total blindness. In India, glaucoma is the leading cause of irreversible blindness with at least 12 million people affected and nearly 1.2 million people blind from the disease. More than 90 percent of glaucoma cases remain undiagnosed in the community.

Thus the high incidence of ophthalmic diseases, resulting in the rise significant patient population, is driving the global ocular drug delivery systems market.

The ocular drug has to pass the water-fat-water membranous structure of the cornea and this changing environment presents a significant barrier. That is why, for almost four decades, researchers have been involved in developing intraocular sustained-release drug delivery platforms.

Owing to the rigorous research studies, approvals for new ocular drug delivery techniques are currently recorded globally. This has helped the market to gain momentum over the last few years.

Key Takeaways from Global Ocular Drug Delivery System Industry Study

  • Increasing focus on pharmaceutical innovation and research on drug delivery technologies is driving a transition towards particulate drug delivery systems, which will account for over 68% of the market in 2021.
  • Ophthalmic solution for ocular drug delivery systems is expected to account for 60% of the global market share by 2031.
  • Among distribution channels, hospital pharmacies accounted for 40% of the market share in 2031. The soaring influx of patients for treatment and the availability of intensive care support has propelled the demand in the segment.
  • North America holds the maximum share, owing to the presence of Tier 1 players, high per-capita healthcare expenditure, and favorable reimbursement policies in the region.
  • The U.S. holds a more than 44% share in the global ocular drug delivery systems market.
  • The U.K. and Germany are leading markets in Europe, accounting for more than 41% of the Europe market in 2021.
  • South Korea is the fastest-growing market in East Asia, exhibiting a 10.3% CAGR through 2031.

“Increasing prevalence of eye infections, innovation in drug delivery technologies, and rising clinical trials are creating lucrative growth opportunities for ocular drug delivery system sales,” says Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.).

Increase in Funding for Research Activities Offers Growth Opportunities

Leading manufacturers in the Global Ocular Drug Delivery System Industry are strengthening their market position through collaboration with various other organizations. Governments in developed and developing countries are actively taking initiatives to encourage research of pharmaceutical products.

For instance, In April 2017, Santen Pharmaceuticals announced a strategic investment in Regenerative Patch Technologies LLC, a U.S.-based company engaged in the development of ophthalmic therapies.

Pharmaceutical giants are expected to benefit from the globalization of labor forces, that is, the employment of skilled local labor at cheaper rates to derive larger cost savings. Furthermore, this will create room for research and development (R&D) investments.

As per data from EFPIA and PhRMA, annual pharmaceutical (R&D) expenditures increased at 2.5% p.a. in Europe as compared to 3.3% p.a. in the U.S. over the latest measurable period 2016-2020. This will also create opportunities for the expansion of the market.

Who is Winning?

The global market is set to expand due to the rising prevalence of eye infections. Leading players within this space are expected to focus on research and development to offer an early and precise diagnosis of ailment, besides offering effective patient care.

Some of the leading players in the Global Ocular Drug Delivery System Industry include but are not limited to Allergan Plc., Graybug Vision Inc., Ocular Therapeutix, Inc., Alimera Sciences, pSivida, Santen Pharmaceutical Co., Ltd, Taiwan Liposome Company Ltd., Envisia Therapeutics, Eyegate Pharma, Valeant Pharmaceuticals International, Inc, Vision Ophthalmology Group GmbH, Clearside Biomedical, URSAPHARM Arzneimittel GmbH.

Want More Insights?

Future Market Insights brings a comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2031. The global ocular drug delivery systems market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provides compelling insights into the ocular drug delivery systems treatment based on the key indication in detail, covering every aspect of the market such as technology, dosage form, and distribution channel across seven major regions.

A Old Full Report Analysis Click Here

Ocular Drug Delivery Systems Market by Category

By Technology:

  • Implantable
  • Particulate
  • Nanoparticle

By Dosage Form:

  • Ophthalmic Solution
  • Ophthalmic Suspension
  • Ophthalmic Emulsion
  • Ophthalmic Gels
  • Ophthalmic Ointments

By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Drug Store
  • Mail Order Pharmacies

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East and Africa (MEA)

 Author

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Femtech Market Projected to Grow to USD 43,406.1 Million by 2034 at a 4.5% of CAGR

Femtech Market
Femtech Market

The global femtech market is on track to achieve a valuation of USD 27,956.4 million in 2024, reflecting continued robust growth from its estimated USD 26,818.2 million in 2023. The market is anticipated to maintain an average growth rate over the next decade, with a compound annual growth rate (CAGR) of 4.5% projected from 2024 to 2034.

By 2034, the femtech market is expected to expand significantly, reaching an estimated USD 43,406.1 million. This growth underscores the increasing investment and innovation in technologies and solutions that address women’s health and wellness issues.

The steady expansion of the femtech sector highlights the rising demand for specialized healthcare products and services tailored to women’s unique needs. As the industry evolves, continued advancements and increased focus on women’s health are anticipated to drive market growth.

Femtech, a rapidly emerging segment of the healthcare industry, offers a range of digital health tools and solutions designed to precisely address the unique healthcare needs of women. From menstrual health management and menopause support to reproductive health and conception tracking, femitech advancements are giving women the power to take control of their health and wellbeing.

Emergence of Femtech Solutions and Technology

This subsegment of the femtech market includes devices, software, and services. The demand for improved diagnostic and treatment choices will expand as infectious and chronic diseases become more common among women, propelling the segment’s growth.

Companies are constantly focusing on developing innovative, cutting-edge techniques to improve women’s health and wellness. The market will expand with improvements made, among other things, to women’s health products.

The primary barriers to the femtech market are described as demography, population fluctuations, and the gap between urban and rural locations. The goal of societal expectations on women’s health, specifically with regard to menstruation, fertility, sexual health, and birth control, is to limit the growth of the market.

Women users’ ignorance of available products and applications may be a barrier to the growth of the femtech industry in developing countries. A fiercely competitive industry is emerging as a result of the growing number of femtech companies, including start-ups.

Because of the increasing number of patients in nations like China and India, the Asia Pacific area is expected to hold one of the largest femtech market shares. Femtech solutions are becoming more and more accepted in the US as a result of growing awareness of women’s health issues, particularly those related to menstruation and fertility.

The main players are focused on providing customized prenatal care, among other services. Femtech services are being used more widely in the nation as a result of these causes. Femtech is gaining traction as seen by the rising incidence of menstrual problems, which is increasing customer acceptability of direct-to-consumer marketing.

Key Takeaways:

  • In the femtech market Diagnostics in the service segment are to grow at a CAGR of 13.2% through 2033.
  • Menstrual Health is expected to accelerate at a CAGR of 12.4% in the femtech market through 2033.
  • During the projection period, the U.S. market for femtech is expected to grow at a CAGR of 12.2% and reach US$ 1.4 Billion by 2033.
  • Femtech sales in the United Kingdom are expected to grow at a CAGR of 14.3% over the forecasted period and hit US$ 274.6 Million by 2033.
  • By 2033, the China femtech market is set to reach US$ 438.9 Million, registering a CAGR of 17.1%.
  • Femtech sales in Japan are likely to increase by a CAGR of 18% over the forecasted period and achieve US$ 368.1 Million by 2033.
  • During the forthcoming years, the market for femtech in South Korea is assumed to expand at a CAGR of 19.9% and attain US$ 107.7 Million by 2033.

Competitive Landscape :

Some of the market leaders in femtech include Flo Health, Inc., Apple, Inc., Clue by Biowink GmbH, Glow, Inc., Google, Inc., Natural Cycles USA Corp., Withings, and Fitbit, Inc. Market players throughout the world are being compelled to provide novel product offerings and technical solutions as a result of the increased demands brought on by the unmet healthcare needs of the female population.

To increase their commercial reach, key participants are concentrating on mergers and acquisitions and technology partnership methods.

A Old Full Report Analysis Click Here

Key Segments :

By Service:

  • Diagnostics
  • Monitoring
  • Therapeutic

By Application:

  • General Health and Wellness
  • Maternity Care
  • Menstrual Health
  • Pelvic and Uterine Healthcare
  • Cancer and Chronic Disease

By End User:

  • Direct-to-consumer
  • Hospitals
  • Surgical Centers
  • Fertility Clinics
  • Diagnostics Centers

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • The Middle East and Africa (MEA)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Urinary Bag Market Set to Exceed USD 1,899.3 Million by 2023, Forecasted to Surge to USD 2,911.7 Million by 2033 at a 4.4% of CAGR

Urinary Bag Market
Urinary Bag Market

The global urinary bag market is on a strong upward trajectory, with projections indicating it will surpass USD 1,899.3 million by the end of 2023. This remarkable growth is set to continue at a compound annual growth rate (CAGR) of 4.4%, pushing the market to an estimated USD 2,911.7 million by 2033.

The market’s expansion is driven by a significant increase in the prevalence of urinary incontinence and urinary retention disorders. As the global population ages and healthcare needs evolve, the demand for effective urinary management solutions has surged.

In addition to this growing demand, there is a heightened focus on sustainability within the urinary bag sector. Manufacturers are responding to environmental concerns by investing in eco-friendly materials and implementing recycling initiatives. These efforts are aligned with a broader trend towards reducing waste and developing sustainable product solutions in the healthcare industry.

The combination of increased prevalence of urinary disorders and a push for environmentally responsible practices is shaping the future of the urinary bag market, promising both growth and innovation in the years ahead.

The emergence of smart and digital solutions has transformed the market. Innovative technologies such as wireless monitoring systems, smart sensors, and mobile applications have been integrated into Urinary Bags. Further, these technologies enable real-time monitoring of urine volume, temperature, and flow rates.

Digital solutions not only enhance patient monitoring but also facilitate remote patient management, reducing the need for frequent hospital visits and improving the efficiency of healthcare delivery.

Access to Urinary Bags can be a challenge, particularly in low-resource settings and developing countries. The availability and affordability of high-quality Urinary Bags may be limited. It may lead to inadequate management of urinary incontinence for patients who cannot afford or access appropriate products.  Addressing this challenge requires a focus on affordability, distribution networks, and increasing awareness about the importance of proper urinary care.

Top Highlights from FMI’s Analysis:

  • In 2022, North America held a value share of 34.5% in the Urinary Bag industry.
  • The market in Europe accounted for a value share of 28.6% in 2022 on a global level.
  • By product type, drainage bags held a substantial value share of 52.24% in 2022.
  • The market value for Urinary Bags reached US$ 1821.0 billion in 2022, with a CAGR of 4.1% from 2018 to 2022.
  • Based on end-use, the hospitals sub-segment was predicted to account for a 40.2% share in 2022.
  • The market for Urinary Bags in India is likely to secure a 6.9% CAGR from 2023 to 2033.

How Fierce Is the Competition in the Urinary Bag Market?

The market consists of both established players with a strong market presence and new entrants striving to gain a foothold. Established companies have a competitive advantage due to their brand reputation, extensive distribution networks, and customer loyalty. Moreover, they often have the resources to invest in research and development, marketing, and strategic partnerships.

Companies in the Urinary Bag market engage in strategic partnerships, collaborations, and acquisitions to strengthen their market position and expand their capabilities. These alliances help in leveraging complementary strengths, accessing new markets, and sharing resources, leading to increased competitiveness in the market.

Ongoing investment in research and development allows companies to develop innovative products, improve existing offerings, and stay ahead of competitors. Companies that invest in research and continuously bring new and improved products to the market have a competitive edge.

Expanding into new geographic regions or targeting niche segments provides opportunities for growth and increased competitiveness. Companies that successfully enter new markets or address specific customer needs, gain an advantage over competitors.

Compliance with regulatory standards and certifications is crucial in the medical device industry, including the market. Manufacturers that meet or exceed regulatory requirements demonstrate their commitment to quality and patient safety, enhancing their competitive position.

Urinary Bag Market Major Players:

  • Medline Industries, Inc.
  • Cardinal Health, Inc.
  • Hollister Incorporated
  • Teleflex Incorporated
  • Cook Medical
  • Moore Medical LLC
  • Mckesson Medical-Surgical Inc.
  • Arcus Medical LLc
  • Urocare
  • Covidien
  • Coloplast A/S
  • Others

A Old Full Report Analysis Click Here

Urinary Bag Market Key Segmentation are:

By Product Type:

  • Drainage Bags
  • Leg Bags
  • Large Capacity Bags
  • Belly Bags

By Capacity:

  • Less than 500 ml
  • 500 ml
  • 1000 ml
  • 2000 ml
  • 4000 ml

By Usage:

  • Reusable Urinary Bags
  • Disposable Urinary Bags

By Patient Age:

  • Pediatric
  • Adult

By End User:

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Long-Term Care Centers
  • Home Care

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI is the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: 
sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Ophthalmic Eye Drop Market Set for Significant Growth, USD 25,876.4 Million by 2034 at a 4.7% of CAGR

Ophthalmic Eye Drop Market
Ophthalmic Eye Drop Market

The global ophthalmic eye drop market is on track for notable expansion, with an anticipated increase from USD 17,271.8 million in 2024 to approximately USD 25,876.4 million by 2034. The market is projected to experience a compound annual growth rate (CAGR) of 4.7% over the forecast period.

In 2023, the ophthalmic eye drop market was valued at USD 16,390.6 million and is expected to show a year-over-year growth of 5.4% in 2024. This growth is driven by increasing prevalence of eye conditions, rising awareness of eye health, and advancements in ophthalmic treatments.

The expansion of the ophthalmic eye drop market reflects a broader trend towards enhanced treatment options and greater access to eye care solutions. Innovations in formulations and delivery mechanisms are contributing to market growth, as well as an increasing focus on personalized medicine and patient-centric care.

New eye drop product launches, branded as well as generic, are expected to be hampered in the short term due to disruptions in the supply chain, delayed pipeline research and development, and a shift in the priority of leading healthcare companies to COVID-19 vaccine and treatment developments.

According to the report, institutional sales of ophthalmic eye drops will rise considerably in the coming years. It will account for over half of ophthalmic eye drops sold through the forecast period.

“Increasing prevalence of eye infections, technological advancements, and high risk of infections from the increasing use of contact lens is expected to boost the growth of the Global Ophthalmic Eye Drops Industry.” says Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.).

Key Takeaways from Global Ophthalmic Eye Drops Industry Study

  • Ophthalmic eye drops market will expand consistently to surpass a valuation of US$ 15 Bn by 2021
  • The U.S. holds over 92.1% share of the North American market, but Canada is projected to expand faster at around 4.0% CAGR
  • Rising cases of eye infection will drive sales in the U.K., enabling it to register 3.9% y-o-y growth in 2021
  • Rising willingness to spend on advanced eye care will drive sales in Germany and France
  • Expansion of the healthcare sector will emerge as the chief growth driver in China and Japan. Both countries will exhibit a high demand for dilation drops

Due to their increasingly active lifestyle and desire for better aesthetics, many people are shifting to contact lenses. However, many ocular infections are associated with the use of contact lenses. Each year in the United States, approximately 1 million eye infections occur related primarily to keratitis, a fungal infection of the cornea, and contact lens infections account for estimated direct costs of $175 million. In addition, 40.9 million U.S. adults wear contact lenses, and 99% of 4,269 contact lens wearers reported at least one contact lens–related hygiene behavior associated with an increased risk for eye infection or inflammation. Nearly a million eye infections requiring a trip to the doctor happen each year, many of them related to contact lens use.

Who is Winning?

The top players are focusing on increasing acquisitions at the regional level. Acquisitions empower the company with products and increase the company’s portfolio. The company acquires other players to possess well-established products and solutions that are expected to become a good revenue source for the acquirer. Acquisitions also enable the company to enter new emerging markets as well as enhance its presence in existing markets. Furthermore, key market players such as Novartis and Gerresheimer AG are focusing on the expansion of their market reach in different regions. For example-

  • In November 2020, Gerresheimer Regensburg announced that it was expanding its production area in Germany. The company has planned the expansion of its production capacity in small batch production, as a result of increasing development projects for pharmaceutical and medical technology products.
  • In November 2019, Sandoz announced that it has entered into a binding agreement for the planned acquisition of the Japanese business of Aspen Global Incorporated (AGI), a wholly owned subsidiary of Aspen Pharmacare Holdings Limited, strengthening its position in the world’s third-largest generics market.

Some of the key market players covered by FMI include Novartis AG, Bausch & Lomb, Akorn, Inc., Biomedica, AdvaCare Pharma, C2 PHARMA, Kraeber GmbH, Iskon Remedies, HANSHIN GROUP, Berry Global Inc., Nolato AB, Bormioli Pharma, WG Pro-Manufacturing Inc., Gerresheimer AG, Adelphi Healthcare Packaging, Aptar Group Inc., and Amcor Plc.

A Old Full Report Analysis Click Here

Global Ophthalmic Eye Drops Industry by CategoryDrug Class

  • Anesthetic Drops
  • Dilation Drops
  • Glaucoma Drops
  • Steroid Drops
  • Antibiotic Drops
  • Others (Antihistamines, Lubricants Tear Drops)

Indication

  • Dry Eye
  • Eye Allergy
  • Glaucoma
  • Eye Infection
  • Retinal Disorders
    • Macular Degeneration
    • Diabetic Retinopathy
    • Others
  • Uveitis
  • Others

Drug Formulation

  • With Preservative
  • Preservative Free

Container Type

  • Single Dose Container
  • Multiple-Dose Container

Distribution Channel

  • Institutional Sales
    • Hospitals
    • Community Clinics
    • Ophthalmic Clinics
    •  Public Health Agencies
    • Veterinary Hospitals & Clinics
  • Retail Sales
    • Retail Pharmacies
    •  Drug Stores

Author

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Skincare Market Set for Dynamic Growth, USD 380,492.2 Million by 2034 at a 8.6% of CAGR

Skincare Market
Skincare Market

The global skincare market is poised for substantial growth, with an estimated market size of USD 166,870.4 million in 2024. According to the latest industry analysis, the market is expected to expand at a robust compound annual growth rate (CAGR) of 8.6% from 2024 to 2034.

By the end of the forecast period in 2034, the demand for skincare products is projected to surge to a remarkable valuation of USD 380,492.2 million. This growth trajectory underscores the increasing consumer focus on skincare and the rising popularity of advanced skincare solutions.

This significant growth is driven by increasing consumer awareness about skincare, rising demand for advanced and personalized skincare solutions, and the expansion of product offerings across various segments. The growing emphasis on maintaining healthy skin, coupled with innovations in skincare technology and formulations, is fueling the market’s upward trajectory.

The skincare market’s expansion reflects a broader trend toward enhanced personal care and wellness, with consumers increasingly seeking products that offer both aesthetic and health benefits. As skincare technology evolves and new trends emerge, the market is poised for continued growth and diversification.

Key Takeaways from Skincare Market Study :

  • Skincare market is expected to rise at 8.6% CAGR between 2024 to 2034
  • The U.K. will remain a key market for skincare products within Europe. Rising demand from various hospitals, healthcare, and critical care centers will continue supporting growth
  • Expansion of the healthcare sector will push growth in Germany, which will account for maximum skincare products sales within Europe’s healthcare sector
  • Strong growth is likely in China, as consumers increasingly focus on hygiene and sanitization to prevent the risk of infection

Competitive Analysis:

The market is characterized by a small number of startups and well-established skincare vendors. Companies have been expanding their product offerings and developing new markets by introducing cosmeceuticals and cutting-edge skin care products to appeal to a wider spectrum of consumers.

In an effort to take the lead in the skincare product market, the main competitors are exploring mergers and acquisitions. In order to solve customers’ persistent problems caused by the aging population and a lack of time for care, skincare producers are reinventing their products and creating sophisticated and specialty categories.

Prominent Skincare Product Manufacturers:

  • 3M Company
  • Cardinal Health, Inc.
  • Ecolab
  • Gojo Industries, Inc.
  • Beiersdorf AG’s NX NIVEA
  • Whiteley Corporation
  • Reckitt Benckiser Group PLC
  • Carroll Clean
  • Johnson & Johnson Consumer Inc.
  • Galderma laboratories, L.P.
  • PDI, Inc.
  • Betco Corporation
  • Pal International
  • PSK Pharma Pvt. Ltd.
  • Metrex Research, LLC.
  • Gojo Industries, Inc.
  • Unilever
  • Steris Plc.
  • Procter & Gamble

A Old Full Report Analysis Click Here

Key Segments:

By Product:

  • Skin Cleansers
  • Hand Sanitizers
  • Surgical Scrubs
  • Skin Care Cosmetics
  • Other

By Skin Type:

  • Normal
  • Dry
  • Oily

By Form:

  • Liquid Skincare
  • Gel and Lotions
  • Wipes
  • Spray and Foams

By End-user:

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Diagnostic Laboratories
  • Reference Laboratories
  • Rehabilitation Centers
  • Long Term Care Centers
  • Critical Care Centers
  • Pharmaceutical and Biotechnology Companies
  • Academics and Research Institutes
  • Homecare Settings

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Asia Pacific
  • Middle East Asia

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Real-Time Bioprocess Raman Analyzer Market Poised for Growth, USD 33.7 Million by 2034 at a 4.8% of CAGR

Real-time Bioprocess Raman Analyzers Market
Real-time Bioprocess Raman Analyzers Market

The global  real-time bioprocess Raman analyzers market is on track to achieve significant growth, with sales expected to reach USD 21.1 million in 2024. According to recent industry analysis, the market is projected to evolve at a compound annual growth rate (CAGR) of 4.8% over the next decade.

By 2034, the real-time bioprocess Raman analyzer market is anticipated to attain a substantial valuation of USD 33.7 million. This growth is driven by the increasing adoption of advanced analytical technologies in bioprocess monitoring and optimization, highlighting the rising demand for precise, real-time data in biopharmaceutical manufacturing processes.

Real-time bioprocess Raman analyzers are becoming increasingly crucial in the life sciences and biotechnology sectors, providing critical insights for process monitoring and quality control in biomanufacturing. Their ability to offer real-time, non-invasive analysis enhances process efficiency and product quality, driving their growing adoption across various industries.

The market’s expansion is attributed to advancements in Raman spectroscopy technology, rising demand for efficient bioprocess monitoring solutions, and the increasing complexity of biopharmaceutical production processes. As companies seek to improve production accuracy and regulatory compliance, the role of real-time bioprocess Raman analyzers is expected to become more prominent.

Key Takeaways from Real-time bioprocess Raman Analyzers Market Study

  • The global Real-time bioprocess Raman Analyzers market is estimated to surpass US$ 8.7 Mn by 2021
  • The U,S, will emerge as dominant market in North America, accounting for over 95% of the overall sales
  • The U.K. will exhibit growth at a positive pace. According to FMI, it is expected to register nearly 20% Y-o-Y growth in 2021
  • Both Germany and France are expected to emerge as attractive markets for realtime bioprocess raman analyzer in Europe
  • Within East Asia, China will account for higher share of proceeds gained by the market
    “Increasing research and development activities are expected to boost the growth for Real-time bioprocess Raman Analyzers Market. On the other hand, there is a rising demand for quality healthcare and pharmaceuticals. This has been creating significant growth opportunities for key players” says the FMI Analyst  

Want more insights?

Future Market Insights (FMI) brings the comprehensive research report on forecast revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2015 to 2030. The global Real-time bioprocess Raman Analyzers market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provides compelling insights on the Real-time bioprocess Raman Analyzers market on basis of a component type (Raman Analysers, Raman Probes, and Software), applications (Lab to Process Analysis and Bioprocess Analysis), and end-users (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Research Organizations) across four major regions.

Who is Winning?

The global market is set to broaden its scope in the forecast period, driven by the increasing adoption rate of real-time and automated solutions during bioprocessing, advancements in technology, and reduced cost in manufacturing of biopharmaceuticals. However, lack of a skilled workforce and inadequate information about the benefits has constrained the sales of Real-time bioprocess Raman Analyzers.

Some of the key players operating in the market are Kaiser Optical Systems (Endress+Hauser), Resolution Spectra Systems Inc. (Merck KGaA), Tornado Spectral Systems, and Sartorius AG. Leading companies are consolidating their positions through mergers, acquisitions, and collaborations.

A Old Full Report Analysis Click Here

Real-time bioprocess Raman Analyzers Market by Category Component Type

  • Instruments
    • Raman Analyzers
    • Raman Probes
  • Software

Application

  • Lab to Process Analysis
  • Bioprocess Analysis

End User

  • Biopharmaceutical Companies
  • Contract Manufacturing Organizations
  • Research Organizations

Region

  • North America
  • Europe
  • Asia Pacific
  • Rest of World

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Pharmaceutical Lipids Market Set for Robust Growth USD 8.04 Billion by 2033 at a 5.0% of CAGR

Pharmaceutical Lipids Market
Pharmaceutical Lipids Market

The global pharmaceutical lipids market is projected to experience steady growth, with an anticipated compound annual growth rate (CAGR) of 5.0% over the forecast period. The market is expected to achieve a revenue of approximately USD 4.93 billion in 2023 and is poised to surpass USD 8.04 billion by 2033.

This growth trajectory reflects the increasing demand for pharmaceutical lipids, driven by their essential role in drug formulation and delivery. Pharmaceutical lipids are crucial for the development of various therapeutic products, including those used in drug delivery systems, nutritional supplements, and advanced medical treatments.

Key factors contributing to the market’s expansion include advancements in lipid-based drug delivery technologies, growing investments in pharmaceutical research and development, and the rising prevalence of chronic diseases requiring innovative treatment solutions.

Furthermore, efforts by governments and regulatory agencies in developed nations, such as the U.S. and the U.K., to streamline the approval process for excipients, are expected to push sales in the market. Because of their cost-effectiveness and patient compliance, oral solid dosage forms are the dominant mode of delivery in the Global Pharmaceutical Lipids Industry and are the preferred option for many pharmaceutical products.

The use of capsules or tablets for drug delivery provides advantages such as increased physical and chemical stability, ease of handling, distinct brand recognition based on colour and shape, and controlled-release options. The majority of liposomal drugs are derived from oral solid drug formulations. The ease of use among patients, particularly children, is expected to boost sales of oral drugs, which will have a direct impact on pharmaceutical lipid sales.

For example, conventional hard solid tablets are difficult to swallow for approximately 50% of patients. This has prompted pharmaceutical companies to create more innovative solid oral product forms, such as effervescent tablets, orally disintegrating granules (ODGs), lozenges, chewable tablets, and instant drinks. This is expected to generate significant demand for liposomal excipients during the forecast period, boosting market growth.

 “Increasing investments in contract manufacturing of pharmaceutical lipids, along with growing demand for oral solid drug formulation is expected to augment the growth in the market over the forecast period,” says an FMI analyst. 

Key Takeaways:

  • Triglyceride sales are expected to account for more than 44.3% of the market by 2032, rising at a 5.1% CAGR during the forecast period.
  • By form, the semi-solid segment commands more than 60.0% of the market in 2021 and is expected to account for 62.7% of the total market share by 2032.
  • In terms of source, sales of semi-synthetic sources will increase at a 5.8% CAGR.
  • In 2021, applications in the conventional lipid-based drug delivery systems (LBDDS) segment held a commanding 64.4% share.
  • The most widely used route of administration will be oral pharmaceutical lipids. In 2021, the segment held 40.8% of the total market share.
  • The U.S. will continue dominating the North America pharmaceutical lipids market over the forecast period owing to the presence of a robust healthcare sector.
  • Demand in the U.K. pharmaceutical lipids market will surge at a 5.1% CAGR over the assessment period.
  • Sales in the India market are slated to increase at a 5.2% CAGR, accounting for a lion’s share in the South Asia pharmaceutical lipids market.

Competition Landscape 

Acquisitions, mergers, expansion, development of an extensive clinical pipeline and product launches are the key strategies adopted by manufacturers to increase the consumer base in various countries. For instance:

  • In July 2020, ABITEC announced the acquisition of Larodan AB, a manufacturer and international marketer of state-of-the-art, high-purity research grade lipids. The acquisition expanded ABITEC’s functional lipid product offerings and scientific capabilities to better serve the pharmaceutical, nutritional, and industrial markets.
  • In January 2020, BASF completed the acquisition of polyamide business of Solvay.
  • In July 2020, Croda International Plc announced the acquisition of Avanti Polar Lipids, Inc., a knowledge-intensive leader in lipid-based drug delivery technologies for the next generation of pharmaceuticals.

Key Companies Profiled

  • ABITEC Corporation (ABF Ingredients)
  • BASF SE
  • Croda International Plc
  • Corden Pharma
  • NOF (Nippon Oil & Fats) Corporation
  • Cayman Chemical Company
  • Lipoid GmbH

A Old Full Report Analysis Click Here

Key Market Segments Covered in Global Pharmaceutical Lipids Industry Research

By Product:

  • Triglycerides
  • Phospholipids
  • Sphingolipids
  • Cholesterol
  • Fatty Acids
  • Others

By Source:

  • Synthetic
  • Semi-synthetic
  • Natural

By Form:

  • Liquid
  • Semi-solid
  • Solid

By Application:

  • Conventional Lipid-based Drug Delivery Systems
  • Self-Emulsifying Drug Delivery Systems
  • Self-Microemulsifying Drug Delivery Systems
  • Liposomes
  • Solid Lipid Nanoparticles
  • Nanostructured Lipid Carriers
  • Others

By Route of Administration:

  • Oral
    • Tablet
    • Solution
  • Parenteral
    • Intravenous
    • Intramuscular (Vaccines)
  • Topical

Author

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Compression Therapy Market Projected to Reach USD 5,925.20 Million by 2034 at a 5.80% of CAGR

Compression Therapy Market
Compression Therapy Market

The compression therapy market is experiencing notable expansion, with recent estimates forecasting revenue to reach approximately USD 3,371.70 million in 2024. Looking ahead, the market is expected to follow a promising growth trajectory, potentially attaining a valuation of USD 5,925.20 million by 2034. This represents a moderate compound annual growth rate (CAGR) of 5.80% over the assessment period.

Several key factors are driving this upward trend, including rising costs associated with sports injuries and automobile accidents, significant advancements in wound care technologies, and the growth of proactive treatments and rehabilitation programs. These elements are collectively fueling increased demand for compression therapy solutions, which play a critical role in managing and recovering from a variety of conditions.

The market’s expansion reflects a broader trend towards enhanced care and recovery options, supported by ongoing innovations and a growing emphasis on effective therapeutic solutions.

Key Takeaways from Compression Therapy Market Study

  • The static compression therapy held the largest market share in 2019 and the trend is expected to continue in the forecast period (2020-2030)
  • Chronic ulcers are expected to hold more than 69% of market share in terms of revenue in 2020
  • Among all distribution channel, institutional sales is the leading segment followed by retail sales. Retail sales segment is anticipated to grow at CAGR of 6% over the forecast period
  • North America and Europe are collectively expected to hold more than 67% of revenue share in 2020 while East Asia is expected to show greater growth potential in the forecast period.

“Acquisitions and launch of compression products along with increasing demand for compression therapy offering increased mobility, enhance athletic performance and safety profiles are driving the growth of global compression therapy market” says the FMI Analyst 

Expansion with Research: The Latest Trend

The compression therapy market players are onto the expansion spree to stand out.

For instance –

In May 2020, British Medical Journal published a study that stated that anti-embolism stockings are all the more effective with respect to DVT (deep vein thrombosis). This finding is bound to influence players to go for production of anti-embolism stockings in the forecast period

Avanos Medical Inc., in the year 2018, announced acquiring CoolSystems, Inc. The products post acquisition were marketed as “Game Ready”

Huntleigh Healthcare Ltd.’s IPC (Intermittent Pneumatic Compression) products under the “Hydroven” brand are a noteworthy addition to vascular assessment systems

Key Participant Insights

The global market is set to broaden its scope in the forecast period, stimulated by high prevalence rate of diabetes, rising geriatric population globally and adoption of advanced compression therapy systems which can be used as bi-layer and multi-layer for conventional treatment option. In addition to this, strict guidelines limits the design space for potential conceptual ideas and availability of alternate therapies has augmented the sales of compression products.

The key market players covered by FMI include:

  1. Paul Hartmann AG,
  2. Sigvaris AG,
  3. Cardinal Health Inc.
  4. 3M Health Care Ltd.

Compression Therapy Market Key Segment

Product Type

  • Pneumatic Compression Therapy
  • Non-Segmented Pneumatic Compression Pumps
  • Pneumatic Compression Sleeves
  • Lower Pneumatic Compression Sleeves
  • Upper Pneumatic Compression Sleeves
  • Segmented Pneumatic Compression Pumps
  • Segmented Pneumatic Compression Pumps with Calibrated Gradient
  • Segmented Pneumatic Compression Pumps without Gradient
  • Static Compression Therapy
  • Anti-Embolism Stockings
  • Compression Bandages
  • Compression Garments
  • Lower Compression Garments
  • Upper Compression Garments

A Old Full Report Analysis Click Here

Compression Therapy Market by Indication:

  • Chronic Ulcers
  • Venous Leg Ulcers
  • Diabetic Foot Ulcers
  • Pressure Ulcers
  • Non-healing Surgical Wounds
  • Traumatic Wounds
  • Burn Cases

Compression Therapy Market by Distribution Channel:

  • Institutional Sales
  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Nursing Facilities
  • Retail Sales
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Sales

Compression Therapy Market by Region:

  • North America Compression Therapy Market
  • Latin America Compression Therapy Market
  • Europe Compression Therapy Market
  • East Asia Compression Therapy Market
  • South Asia & Pacific Compression Therapy Market
  • Middle East & Africa (MEA) Compression Therapy Market

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI is the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Orthopedic Braces and Support Market Projected to Reach USD 8.8 Billion by 2034, Growing at a CAGR of 6.7%

Orthopedic Braces and Support
Orthopedic Braces and Support

The global orthopedic braces and support market is set for significant growth, with projections indicating a rise from an estimated valuation of USD 4.6 billion in 2024 to approximately USD 8.8 billion by 2034. This growth trajectory reflects a robust compound annual growth rate (CAGR) of 6.7% over the assessment period.

The expanding market is driven by an increasing prevalence of musculoskeletal disorders, a rising aging population, and growing awareness of orthopedic health. Technological advancements in brace and support design, along with a growing focus on preventive care and rehabilitation, are further contributing to market expansion.

The orthopedic braces and support market encompasses a wide range of products designed to assist in the treatment and management of various orthopedic conditions, enhancing mobility and providing support for individuals recovering from injuries or surgeries.

The healthcare industry is embracing technological intervention with digital health, virtual health, and telehealth to treat patients.

Such trends are emerging as a potential disruptor in the orthopedic braces and support market, which has been facing the brunt of the COVID-19 pandemic.

Key Takeaways :

  • Rising Incidence of Orthopedic Disorders: The prevalence of orthopedic conditions such as osteoarthritis, osteoporosis, and sports injuries is increasing globally, leading to a growing demand for orthopedic braces and support products.
  • Increasing Awareness and Adoption: There is a growing awareness among patients and healthcare professionals about the benefits of using orthopedic braces and supports for rehabilitation, injury prevention, and pain management, driving the adoption of these products.
  • Technological Advancements: Advances in materials science and manufacturing technologies are enabling the development of lightweight, ergonomic, and customizable orthopedic braces and support solutions, enhancing patient comfort and compliance.

As the global population continues to age and lifestyles become increasingly sedentary, the demand for orthopedic braces and support products is expected to witness sustained growth in the coming years.

Top Recommended Strategies to Stay Ahead of Market Competition:

  • Key players can use smart sensors, materials, and biofeedback mechanisms to provide rehabilitation experiences and personalized support for effective rehabilitation bracing solutions.
  • Companies need to prioritize research to develop new materials, applications, and designs for braces and support to effectively meet the needs of patients and align with emerging trends.
  • Industry participants can consider collaborating with experts to prepare products validated for science and practical use cases.
  • Market contenders can offer customization options like personalized support levels and custom-fit braces to meet individual needs effectively.
  • By focusing on streamlining the purchase process, like offering hassle-free returns and convenient online ordering options, players can build loyalty and trust among their target market.

Recent Developments

  • In October 2023, OrthoPediatrics Corp. launched the DF2 Brace as a strategy to expand into non-surgical business to treat kids suffering from musculoskeletal injuries.
  • In September 2023, Enovis Corporation officially disclosed the acquisition of LimaCorporate S.p.A. The acquisition of the latter company added a wide variety of orthopedic medical devices like braces and other support apparatus.

Key Players in the Orthopedic Braces and Support Industry:

  • DJO, LLC (United States)
  • Zimmer Biomet (United States
  • Medtronic (Ireland)
  • Stryker Corporation (United States)
  • Össur (Iceland)
  • NuVasive®, Inc (United States)
  • Integra LifeSciences Corporation (United States)
  • Globus Medical (United States)
  • OTTOBOCK (Germany)
  • AC Mould Engineering Limited (China)
  • Johnson and Johnson Services, Inc (United States)
  • Weber Orthopedic LP. DBA Hely and Webe (United States)
  • BSN medical (India)
  • Becker Orthopedic (United States)
  • OPPO MEDICAL INC (United States)
  • Langer Biomechanics (United States)
  • Frank Stubbs Company Inc. (United States)
  • DeRoyal Industries, Inc (United States)
  • Ascent Meditech Limited (India)
  • Alcare Co., Ltd (Tokyo)
  • Others

Orthopedic Braces and Support Industry by Category:

By Product:

  • Braces and Supports Type
    • Knee Braces for Osteoarthritis and Ligament Injuries
    • Post-operational Knee Braces
    • Upper Spine Orthoses
    • TLSOs
    • LSOs
    • Soft Braces
    • Hinged Braces
    • Pneumatic
    • Non-pneumatic
    • Elbow Braces and Supports
    • Wrist Braces and Supports
  • Pain Management Products
    • Cold Therapy Products
    • DVT Products

By End-user:

  • Orthopedic Clinics
  • Over the Counter (OTC)
  • Hospitals
  • DME Dealers
  • Others

By Region:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • South Asia and the Pacific
  • East Asia
  • Middle East and Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube